E

Aequus Pharmaceuticals Inc. AQS.V

TSX
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Aequus Pharmaceuticals Inc. is a Canadian specialty pharmaceutical company focused on acquiring, in-licensing, and commercializing prescription products that address unmet medical needs. The company operates primarily within the pharmaceuticals and healthcare industry, with an emphasis on niche therapeutic areas where it can leverage targeted sales, regulatory expertise, and partner-driven development. Its business model centers on late-stage or already-approved products, reducing early-stage development risk.

The company was incorporated in 2013 and is headquartered in Vancouver, Canada. Since inception, Aequus has evolved from an early-stage specialty pharma company into a commercial-stage organization with a portfolio strategy based on regional licensing, co-development, and commercialization partnerships. Its positioning is defined by a capital-efficient approach, reliance on external manufacturing and development partners, and a focus on products with defined regulatory pathways.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Friday, November 28, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
(est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
604 336 7906
Address
200 Granville Street
Suite 2820
Vancouver, BC V6C 1S4
Country
Year Founded

Headlines

There are no news to display.